“Engaged in research with new mechanisms of action”

2023-09-15 15:34:40

“ViiV is a company that is totally dedicating itself to research in the HIV field, in particular with the development of new molecules and new mechanisms of action”. These are the words of Cristina Zocchetti, medical director of ViiV Healthcare Italy and Holland, on the sidelines of the closing day of the Icona , reserved for young specialists or trainees structured in Infectious Diseases related to the Icona centres.